accountprostate cancer and because of its cash. The Dimebon failure increases Pfizer's dependence on cost-cutting from its Wyeth mega-acquisition to shore up profits as it faces looming generic competition to its blockbuster Lipitor cholesterol drug, BMO...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Medivation, Pfizer Alzheimer's drug fails study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account